2005
DOI: 10.5414/cpp43294
|View full text |Cite
|
Sign up to set email alerts
|

An evaluation of prescribing errors in primary care in Bahrain

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
62
5

Year Published

2007
2007
2021
2021

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(72 citation statements)
references
References 0 publications
5
62
5
Order By: Relevance
“…Type A errors in our study were 48.0%. These findings were similar in Bahrain (31.0%) [11] and Oman (22.11%) studies [12]. In other study, that analyzed mistakes in prescriptions in…”
Section: Discussionsupporting
confidence: 73%
See 2 more Smart Citations
“…Type A errors in our study were 48.0%. These findings were similar in Bahrain (31.0%) [11] and Oman (22.11%) studies [12]. In other study, that analyzed mistakes in prescriptions in…”
Section: Discussionsupporting
confidence: 73%
“…From our study the most commonly prescribed pharmacological groups of prescribed medications were NSAIDs (21.1%) and antibiotics (20.0%), which was similar to the Nadiya et.al study in Oman, where NSAIDs were prescribed in 35.11% and antibiotics in 18.22% of prescriptions [11]. According to the literature review the dose corresponded to type A errors.…”
Section: Discussionsupporting
confidence: 67%
See 1 more Smart Citation
“…Over/ underutilization of medications were seen in 23% of patient encounters. This figure was quite higher than that of Bahraini and Mexican study findings 19,25 .…”
Section: Issn: 0975-8232contrasting
confidence: 70%
“…Medication errors cause more harm in children compared to adult counterparts [5][6] because most pediatric drug doses are calculated based on the age, body weight,body surface area and other clinical conditions. Majority of the drugs used in the children are an unlicensed and off-label and may lead to adverse drug events and sometimes death [7][8][9][10][11][12]. There are extremely limited number of clinical studies due to different groups in pediatric population which includes from neonates to adolescents and in addition pharmaceutical companies are less keen on conducting the specific clinical trials for pediatric patients as they are more challenging and when compared to adult drug market pediatric drug market is smaller [13].…”
Section: Introductionmentioning
confidence: 99%